| Page 149 | Rogel Cancer Center | University of Michigan

skip to main content

MDS Risk Factors Most of the time, doctors don't know the exact cause of MDS. A risk factor is anything that increases your chance of developing a disease such as cancer. But risk factors don't tell us everything. People that do not have any risk factors can still get the disease. Having a risk factor, or even several, does not mean that you will get the disease. Read more about MDS Risk Factors	Cutting through sunscreen confusion This article has moved. You can now read it as Sunscreen Prevents Skin Cancer. Read more about Cutting through sunscreen confusion	Sarcoma Survivor Stories The content on this page has moved. To read survivorship stores, please visit the Survivorship section or Sharing Hope section in Living with Cancer. Read more about Sarcoma Survivor Stories	Lung cancer clues found in downstream pathway A new study from researchers at the University of Michigan Rogel Cancer Center sheds light on the KRAS pathway with a potential target that might have more success at stopping lung cancer growth. Read more about Lung cancer clues found in downstream pathway
U-M researchers get $1.5M grant to develop customized pancreatic cancer treatment Media contact: Nicole Fawcett, 734-764-2220 \| Patients may contact Cancer AnswerLine™, 800-865-1125 ANN ARBOR, Mich. — One day, a pancreatic cancer patient will provide a blood sample and doctors will recommend treatments designed to target all the harmful cell’s in the individual’s tumor. This is the vision of pancreatic cancer researchers at the University of Michigan Rogel Cancer Center. Read more about U-M researchers get $1.5M grant to develop customized pancreatic cancer treatment	Researchers open ‘Pandora’s box’ of potential cancer biomarkers Researchers at the University of Michigan Rogel Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored. This analysis opens the door to discovery of thousands of potential new cancer biomarkers. Read more about Researchers open ‘Pandora’s box’ of potential cancer biomarkers	What makes pancreatic cancer so aggressive? New study sheds light Media contact: Nicole Fawcett, 734-764-2220 \| Patients may contact Cancer AnswerLine, 800-865-1125 ANN ARBOR, Mich. – New research from the University of Michigan Rogel Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease. Read more about What makes pancreatic cancer so aggressive? New study sheds light	New sequencing technique reveals genetic clues to rare breast tumors A new study characterizes the genetic underpinnings of a rare type of breast tumor called phyllodes tumors, offering the first comprehensive analysis of the molecular alterations at work in these tumors. Read more about New sequencing technique reveals genetic clues to rare breast tumors
Steven J. Katz MD Read more about Steven J. Katz MD	Researchers uncover key cancer-promoting gene One of the mysteries in cancer biology is how one protein, TGF-beta, can both stop cancer from forming and encourage its aggressive growth. Now, researchers at the University of Michigan Rogel Cancer Center have uncovered a key gene that may explain this paradox and provide a potential target for treatment. Read more about Researchers uncover key cancer-promoting gene

Pages